Showing results (51-60 of 406) with videos related to

Sort By:
Pageof 41
The Oncologist|November 4, 2011
Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel settingOliver Sartor, Ross M Michels, Christophe Massard, et al.
Investigational New Drugs|December 15, 2010
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapyYoulia M Kirova, Vincent Servois, Cyrus Chargari, et al.
European Urology|August 30, 2005
Trastuzumab (Herceptin) in metastatic transitional cell carcinoma of the urinary tract: report on six patientsMichaël Peyromaure, Florian Scotté, Delphine Amsellem-Ouazana, et al.
Bulletin Du Cancer|March 21, 2007
[Reflexion on innovation diffusion factors: the case of Herceptin]Catherine Buron, Marianne Doz, Anne Vincent Salomon, et al.
Expert Opinion on Drug Safety|May 5, 2016
Safety of available treatment options for renal cell carcinomaLisa Derosa, Laurence Albiges, Christophe Massard, et al.
Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Leiomyosarcoma of the renal pelvis]Michaël Peyromaure, Kaili Mao, Eva Compérat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Bulletin of synthesis 2005. Recommendations for clinical practice. Management of non metastatic prostate cancer]Michel Soulie, Philippe Beuzeboc, Pierre Richaud, et al.
Bulletin Du Cancer|May 5, 2011
[Brain metastases from breast cancer: usefulness and limits of prognostic scores]Romuald Le Scodan, Christophe Massard, Ludivine Jouanneau, et al.
Bulletin Du Cancer|June 15, 2011
[Cell cycle, mitosis and therapeutic applications]Antonin Levy, Laurence Albiges-Sauvin, Christophe Massard, et al.
Pageof 41